Showing results (1861-1870 of 1,933) with videos related to

Sort By:
Pageof 194
BMC Cancer|March 26, 2021
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trialE E A P Mulder, K de Joode, S Litière, et al.
Annals of Internal Medicine|February 15, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort StudyMonique K van der Kooij, Karijn P M Suijkerbuijk, Maureen J B Aarts, et al.
Cancers|January 21, 2023
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome AnalysisMelissa M De Meza, Willeke A M Blokx, Johannes J Bonenkamp, et al.
Cancers|July 31, 2020
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and ResponseMonique K van der Kooij, Marjolein J A L Wetzels, Maureen J B Aarts, et al.
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.
Cancers|October 23, 2021
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The NetherlandsJesper van Breeschoten, Alfonsus J M van den Eertwegh, Liesbeth C de Wreede, et al.
Cancers|August 10, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma PatientsDaan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, et al.
JAMA Network Open|August 14, 2024
Long-Term Survival in Patients With Advanced MelanomaOlivier J van Not, Alfons J M van den Eertwegh, Hilde Jalving, et al.
Melanoma Research|December 22, 2020
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastasesRawa K Ismail, Nienke O Sikkes, Michel W J M Wouters, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2020
Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based studyMichiel C T van Zeijl, Florine L Boer, Mariëtte I E van Poelgeest, et al.
Pageof 194